Jean‐Marie Vandenbulcke

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

D. Machover, Emma Goldschmidt, P. Chollet et al. · Journal of Clinical Oncology · 1986 · 397 citations

Medicine, Oncology, Pharmacotherapy +10

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois et al. · Annals of Oncology · 2012 · 124 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase <scp>II</scp> study of dual phosphoinositol‐3‐kinase ( <scp>PI</scp> 3K) and mammalian target of rapamycin ( <scp>mTOR</scp> ) inhibitor <scp>BEZ</scp> 235 in patients with locally advanced or metastatic transitional cell carcinoma

Emmanuel Seront, Sylvie Rottey, Bertrand Filleul et al. · British Journal of Urology · 2016 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy

Jean‐Pascal Machiels, Aline van Maanen, Jean‐Marie Vandenbulcke et al. · The Oncologist · 2016 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16

O-099 XYOTAX™ vs. docetaxel for the second-line treatment of non-small cell lung cancer (NSCLC): The STELLAR 2 phase III study

P. Bonomi, Luis Paz‐Ares, Corey J. Langer et al. · Lung Cancer · 2005 · 12 citations

Medicine, Oncology, Pharmacology +9